TY - JOUR
T1 - Neurotoxicity of interferon-α
AU - Merimsky, O.
AU - Chaitchik, S.
PY - 1992
Y1 - 1992
N2 - Interferon (IFN) related neurotoxicity includes somnolence and confusion, fatigue, lethargy, psychiatric symptoms, conceptual disorganization, neurological deficits, cortical blindness, coma and, rarely, death. The neurologic syndromes seem to be more common in elderly patients, following intramuscular or intravenous administration, at higher doses or frequent injections of IFN-α and in primary renal cell carcinoma. The duration of the treatment was not strongly related to neurotoxicity. Computed tomography findings were non-specific and included atrophy or periventricular lucencies. Electroencephalograph studies demonstrated a generalized increase in slow wave activity which returned to normal after cessation of treatment. Behavioral and mental changes in patients treated with IFN are warning signs, and indicate the need to withdraw treatment.
AB - Interferon (IFN) related neurotoxicity includes somnolence and confusion, fatigue, lethargy, psychiatric symptoms, conceptual disorganization, neurological deficits, cortical blindness, coma and, rarely, death. The neurologic syndromes seem to be more common in elderly patients, following intramuscular or intravenous administration, at higher doses or frequent injections of IFN-α and in primary renal cell carcinoma. The duration of the treatment was not strongly related to neurotoxicity. Computed tomography findings were non-specific and included atrophy or periventricular lucencies. Electroencephalograph studies demonstrated a generalized increase in slow wave activity which returned to normal after cessation of treatment. Behavioral and mental changes in patients treated with IFN are warning signs, and indicate the need to withdraw treatment.
UR - http://www.scopus.com/inward/record.url?scp=0027066790&partnerID=8YFLogxK
U2 - 10.1097/00001813-199212000-00002
DO - 10.1097/00001813-199212000-00002
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 1288726
AN - SCOPUS:0027066790
SN - 0959-4973
VL - 3
SP - 567
EP - 570
JO - Anti-Cancer Drugs
JF - Anti-Cancer Drugs
IS - 6
ER -